Dermatology

Epidermolysis bullosa (EB) places a significant socioeconomic burden on patients. Several reports stated that Epidermolysis bullosa had a considerable negative impact on the quality of the lives of patients. Although it is a rare disease, EB is a cause of significant morbidity and mortality among the affected individuals. It is observed that EB affects 1 in 30,000 to 50,000 people. As per DelveInsight estimates, the total Epidermolysis bullosa prevalent population in the 7MM (the US, EU5 (the UK, Germany, France, Spain, and Italy) and Japan) was 41,509 in 2017.   Epidermolysis bullosa is a group of heterogeneous congenital conditions that causes blisters ...